Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis

<p>Abstract</p> <p>Background</p> <p>Tuberculosis causes 3 million deaths annually. The most common site of tuberculosis is pulmonary however; extra-pulmonary forms of the disease also remain prevalent. Restriction of <it>Mycobacterium tuberculosis </it>depe...

Full description

Bibliographic Details
Main Authors: Khan M Aslam, Jamil Bushra, Zaidi Irfan, Hasan Zahra, Kanji Akbar, Hussain Rabia
Format: Article
Language:English
Published: BMC 2005-07-01
Series:BMC Immunology
Online Access:http://www.biomedcentral.com/1471-2172/6/14
id doaj-c3ed7c339d6847d68fe20e5214f6bb5a
record_format Article
spelling doaj-c3ed7c339d6847d68fe20e5214f6bb5a2020-11-25T02:58:05ZengBMCBMC Immunology1471-21722005-07-01611410.1186/1471-2172-6-14Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosisKhan M AslamJamil BushraZaidi IrfanHasan ZahraKanji AkbarHussain Rabia<p>Abstract</p> <p>Background</p> <p>Tuberculosis causes 3 million deaths annually. The most common site of tuberculosis is pulmonary however; extra-pulmonary forms of the disease also remain prevalent. Restriction of <it>Mycobacterium tuberculosis </it>depends on effective recruitment and subsequent activation of T lymphocytes, mononuclear and polymorphonuclear cells to the site of infection. Tumor necrosis factor (TNF)-α is essential for granuloma formation and is a potent activator of monocyte chemotactic protein (MCP-1, CCL2). CCL2 is essential for recruitment of monocytes and T cells and has been shown to play a role in protection against tuberculosis. Interleukin -8 (CXCL8) is a potent activator of neutrophils. Increased levels of CCL2, CXCL8 and TNFα are reported in tuberculosis but their significance in different forms of tuberculosis is as yet unclear. We have used an <it>ex vivo </it>assay to investigate differences in immune parameters in patients with either pulmonary or extra-pulmonary tuberculosis.</p> <p>Methods</p> <p>Serum levels of CCL2, CXCL8 and TNFα were measured in patients with pulmonary tuberculosis (N = 12), extra-pulmonary tuberculosis (N = 8) and BCG-vaccinated healthy volunteers (N = 12). Whole blood cells were stimulated with non-pathogenic <it>Mycobacterium bovis </it>bacille-Calmette Guerin (BCG) vaccine strain or bacterial lipopolysaccharide (LPS) and cyto/chemokines were monitored in supernatants.</p> <p>Results</p> <p>Circulating serum levels of CXCL8 and TNFα were raised in all tuberculosis patients, while CCL2 levels were not. There was no difference in spontaneous cytokine secretion from whole blood cells between patients and controls. <it>M. bovis </it>BCG-induced <it>ex vivo </it>CCL2 secretion was significantly greater in pulmonary as compared with both extra-pulmonary tuberculosis patients and endemic controls. In response to LPS stimulation, patients with pulmonary tuberculosis showed increased CCL2 and TNFα responses as compared with the extra-pulmonary group. BCG-, and LPS-induced CXCL8 secretion was comparable between patients and controls.</p> <p>Conclusion</p> <p>CCL2 is activated by TNFα and is essential for recruitment of monocytes and T cells to the site of mycobacterial infection. Increased CCL2 activation in pulmonary tuberculosis may result in a stronger cellular response as compared with extra-pulmonary tuberculosis patients, and this may contribute to the localization of infection to the pulmonary site.</p> http://www.biomedcentral.com/1471-2172/6/14
collection DOAJ
language English
format Article
sources DOAJ
author Khan M Aslam
Jamil Bushra
Zaidi Irfan
Hasan Zahra
Kanji Akbar
Hussain Rabia
spellingShingle Khan M Aslam
Jamil Bushra
Zaidi Irfan
Hasan Zahra
Kanji Akbar
Hussain Rabia
Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis
BMC Immunology
author_facet Khan M Aslam
Jamil Bushra
Zaidi Irfan
Hasan Zahra
Kanji Akbar
Hussain Rabia
author_sort Khan M Aslam
title Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis
title_short Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis
title_full Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis
title_fullStr Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis
title_full_unstemmed Elevated <it>ex vivo </it>monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis
title_sort elevated <it>ex vivo </it>monocyte chemotactic protein-1 (ccl2) in pulmonary as compared with extra-pulmonary tuberculosis
publisher BMC
series BMC Immunology
issn 1471-2172
publishDate 2005-07-01
description <p>Abstract</p> <p>Background</p> <p>Tuberculosis causes 3 million deaths annually. The most common site of tuberculosis is pulmonary however; extra-pulmonary forms of the disease also remain prevalent. Restriction of <it>Mycobacterium tuberculosis </it>depends on effective recruitment and subsequent activation of T lymphocytes, mononuclear and polymorphonuclear cells to the site of infection. Tumor necrosis factor (TNF)-α is essential for granuloma formation and is a potent activator of monocyte chemotactic protein (MCP-1, CCL2). CCL2 is essential for recruitment of monocytes and T cells and has been shown to play a role in protection against tuberculosis. Interleukin -8 (CXCL8) is a potent activator of neutrophils. Increased levels of CCL2, CXCL8 and TNFα are reported in tuberculosis but their significance in different forms of tuberculosis is as yet unclear. We have used an <it>ex vivo </it>assay to investigate differences in immune parameters in patients with either pulmonary or extra-pulmonary tuberculosis.</p> <p>Methods</p> <p>Serum levels of CCL2, CXCL8 and TNFα were measured in patients with pulmonary tuberculosis (N = 12), extra-pulmonary tuberculosis (N = 8) and BCG-vaccinated healthy volunteers (N = 12). Whole blood cells were stimulated with non-pathogenic <it>Mycobacterium bovis </it>bacille-Calmette Guerin (BCG) vaccine strain or bacterial lipopolysaccharide (LPS) and cyto/chemokines were monitored in supernatants.</p> <p>Results</p> <p>Circulating serum levels of CXCL8 and TNFα were raised in all tuberculosis patients, while CCL2 levels were not. There was no difference in spontaneous cytokine secretion from whole blood cells between patients and controls. <it>M. bovis </it>BCG-induced <it>ex vivo </it>CCL2 secretion was significantly greater in pulmonary as compared with both extra-pulmonary tuberculosis patients and endemic controls. In response to LPS stimulation, patients with pulmonary tuberculosis showed increased CCL2 and TNFα responses as compared with the extra-pulmonary group. BCG-, and LPS-induced CXCL8 secretion was comparable between patients and controls.</p> <p>Conclusion</p> <p>CCL2 is activated by TNFα and is essential for recruitment of monocytes and T cells to the site of mycobacterial infection. Increased CCL2 activation in pulmonary tuberculosis may result in a stronger cellular response as compared with extra-pulmonary tuberculosis patients, and this may contribute to the localization of infection to the pulmonary site.</p>
url http://www.biomedcentral.com/1471-2172/6/14
work_keys_str_mv AT khanmaslam elevateditexvivoitmonocytechemotacticprotein1ccl2inpulmonaryascomparedwithextrapulmonarytuberculosis
AT jamilbushra elevateditexvivoitmonocytechemotacticprotein1ccl2inpulmonaryascomparedwithextrapulmonarytuberculosis
AT zaidiirfan elevateditexvivoitmonocytechemotacticprotein1ccl2inpulmonaryascomparedwithextrapulmonarytuberculosis
AT hasanzahra elevateditexvivoitmonocytechemotacticprotein1ccl2inpulmonaryascomparedwithextrapulmonarytuberculosis
AT kanjiakbar elevateditexvivoitmonocytechemotacticprotein1ccl2inpulmonaryascomparedwithextrapulmonarytuberculosis
AT hussainrabia elevateditexvivoitmonocytechemotacticprotein1ccl2inpulmonaryascomparedwithextrapulmonarytuberculosis
_version_ 1724708630239903744